NRGN and Alzheimer disease: To test the utility of plasma Ng, De Vos and colleagues measured, by enzyme-linked immunosorbent assay (ELISA), the C-terminal portion of Ng in paired CSF and plasma samples of 29 controls compared to 29 MCI patients or those with dementia due to AD.